SCHEMBL19954609

SCHEMBL19954609

CCc1cc(C(F)(F)F)nn1C1CCC(NS(C)(=O)=O)CC1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.42
GRIA2 P42262 3/20 0.40
AR P10275 1/20 0.38
CCR2 P41597 1/20 0.37
KCNH2 Q12809 1/20 0.37
TRPV4 Q9HBA0 1/20 0.36
LRRK2 Q5S007 2/20 0.35
SMO Q99835 1/20 0.34
BTK Q06187 1/20 0.34
KDM1A O60341 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
JAK1 P23458 1/20 0.33
HTR2A P28223 1/20 0.33
DRD3 P35462 1/20 0.33
NR3C2 P08235 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19954602 0.93 AR (0.41) TRPV1GRIA2ARCCR2KCNH2
SCHEMBL18164068 0.84 AR (0.39) TRPV1GRIA2ARCCR2KCNH2
SCHEMBL19954538 0.81 AR (0.40) TRPV1GRIA2ARCCR2KCNH2
SCHEMBL21024103 0.79 TRPV1 (0.42) TRPV1KCNH2LRRK2NR3C2
SCHEMBL21023833 0.79 TRPV1 (0.40) TRPV1GRIA2KCNH2LRRK2NR3C2
SCHEMBL18164095 0.77 AR (0.43) TRPV1ARCCR2KCNH2TRPV4
SCHEMBL19954622 0.76 GAA (0.37) TRPV1KCNH2LRRK2HTR2ANR3C2
SCHEMBL19954587 0.75 AR (0.41) TRPV1GRIA2ARCCR2KCNH2
SCHEMBL19954551 0.71 TRPV1 (0.35) TRPV1GRIA2LRRK2NR3C2
SCHEMBL21023570 0.71 NR3C2 (0.38) TRPV1NR3C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9914706-B2 N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2018-03-13 US disclosed